Albemarle Corporation logo

Albemarle Corporation

ALB

NYSEBasic MaterialsChemicals - Specialty

Previous close

$143.25

+$9.06 · +6.75%

Aug 21, 4:00 PM ET

ALB company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

28

Expensive

Momentum

29

Weakening

Sentiment

54

Mixed

Risk resilience

40

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.

Industry
Chemicals - Specialty
Sector
Basic Materials
Headquarters
US
CEO
Jerry Kent Jr.
Listed since
Feb 22, 1994
Employees
7,800

Market position

Day range

Current $143.25

52-week range

Current $143.25

Open
$138.99
Previous close
$134.19
Volume
3.22M
1.4× average
Average volume
2.3M
Average daily volume
Market cap
16.89B USD
Beta
1.32
Market reference 1
50-day average
$132.74
+7.92% above average
200-day average
$155
-7.58% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
18.33B USD
EV / EBITDA
32.73×
Earnings yield
-3.07%
Free cash flow yield
4.16%

Profitability & efficiency

Return on equity
-5.36%
Return on assets
-3.12%
Return on invested capital
0.64%

Financial health

Current ratio
2.23×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends49%23%-3%-28%Gross margin, FY2021: 30.30%Gross margin, FY2022: 42.15%Gross margin, FY2023: 12.49%Gross margin, FY2024: 1.12%Gross margin, FY2025: 13.06%Operating margin, FY2021: 16.01%Operating margin, FY2022: 34.17%Operating margin, FY2023: 2.51%Operating margin, FY2024: -11.83%Operating margin, FY2025: 1.82%Net margin, FY2021: 3.72%Net margin, FY2022: 36.75%Net margin, FY2023: 16.36%Net margin, FY2024: -21.93%Net margin, FY2025: -9.93%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 30.30%. Gross margin FY2022 42.15%. Gross margin FY2023 12.49%. Gross margin FY2024 1.12%. Gross margin FY2025 13.06%. Operating margin FY2021 16.01%. Operating margin FY2022 34.17%. Operating margin FY2023 2.51%. Operating margin FY2024 -11.83%. Operating margin FY2025 1.82%. Net margin FY2021 3.72%. Net margin FY2022 36.75%. Net margin FY2023 16.36%. Net margin FY2024 -21.93%. Net margin FY2025 -9.93%.

Income trends

Revenue

5.14B USD-4.37%

Operating income

93.79M USD+729.79M USD

Net income

−510.63M USD+56.71%
Income trends across reported periods10.7B USD6.38B USD2.06B USD−2.26B USDRevenue, FY2021: 3.33B USDRevenue, FY2022: 7.32B USDRevenue, FY2023: 9.62B USDRevenue, FY2024: 5.38B USDRevenue, FY2025: 5.14B USDOperating income, FY2021: 532.66M USDOperating income, FY2022: 2.5B USDOperating income, FY2023: 241.12M USDOperating income, FY2024: −636.01M USDOperating income, FY2025: 93.79M USDNet income, FY2021: 123.67M USDNet income, FY2022: 2.69B USDNet income, FY2023: 1.57B USDNet income, FY2024: −1.18B USDNet income, FY2025: −510.63M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 3.33B USD. Revenue FY2022 7.32B USD. Revenue FY2023 9.62B USD. Revenue FY2024 5.38B USD. Revenue FY2025 5.14B USD. Operating income FY2021 532.66M USD. Operating income FY2022 2.5B USD. Operating income FY2023 241.12M USD. Operating income FY2024 −636.01M USD. Operating income FY2025 93.79M USD. Net income FY2021 123.67M USD. Net income FY2022 2.69B USD. Net income FY2023 1.57B USD. Net income FY2024 −1.18B USD. Net income FY2025 −510.63M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue5.14B USD5.38B USD9.62B USD7.32B USD3.33B USD
Cost of goods sold4.47B USD5.32B USD8.42B USD4.23B USD2.32B USD
Gross profit671.62M USD60.24M USD1.2B USD3.09B USD1.01B USD
Research and development51.4M USD86.72M USD85.73M USD71.98M USD54.03M USD
Selling, general, and administrative526.43M USD609.53M USD874.16M USD512.15M USD421.79M USD
Operating expenses577.83M USD696.25M USD959.89M USD584.13M USD475.81M USD
Interest expense207.65M USD165.62M USD116.07M USD122.97M USD61.48M USD
Depreciation and amortization660.58M USD590.94M USD429.94M USD300.84M USD254M USD
Operating income93.79M USD−636.01M USD241.12M USD2.5B USD532.66M USD
Net income−510.63M USD−1.18B USD1.57B USD2.69B USD123.67M USD

Company facts updated Aug 24, 2026.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

45 ratings
Strong buy00%
Buy1942%
Hold2044%
Sell613%
Strong sell00%

Recent analyst actions

12 institutions
Argus ResearchmaintainBuy

ALB news

ALB peers

ETFs holding ALB

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research ALB

research.disclaimer